epcoritamab
abbvie,genmab
['epcoritamab', 'lymsm', 'lymphoma', ' epco ', 'dlbcl']
#ash22 #lymsm #dlbcl
abrisqueta et al sc epcoritamab+r-dhac/x in rr dlbcl asct eligible ph 1/2
n=29 58y (28-75)
16 pts had asct after 3 cycles
5 continued epco without asct cr 81% in asct pts 45% in no asct
short fu 12.6 mo pfs nr v active combo (more than pola-rice) 
Clinician-researcher-educator bookworm @RoswellPark. Passionate about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews